PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.81
Similar ESG score to SGMO's 59.42. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
54.80
Similar environmental score to SGMO's 53.46. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
57.90
Social score 80-90% of SGMO's 64.47. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.72
Similar governance score to SGMO's 60.33. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.